Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

NCT04047953 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma

Interventions

DRUG: Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1

Sponsor

Peking University Cancer Hospital & Institute